Position in TRVI
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,669,957
+$1,895,157 QoQ
Shares Held
223,802
-13.9% QoQ
Ownership
0.158%
of shares outstanding
% of Portfolio
1.68%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
3 quarters on record
Voting authority
Sole 70.77237915657591.ToString("F0")%
Shared 29.227620843424095.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Propel Bio Management, LLC holds $111,641,854 across 34 Biotechnology names. TRVI ranks #18 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACHV |
Achieve Life Sciences, Inc.
|
3,786,425 | $11,132,089 | |
| 2 | PHAT |
Phathom Pharmaceuticals, Inc.
|
841,272 | $9,346,531 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
147,828 | $5,958,946 | |
| 4 | ABEO |
Abeona Therapeutics Inc.
|
1,329,899 | $5,957,947 | |
| 5 | VOR |
Vor Biopharma Inc.
|
314,543 | $5,611,447 | |
| 6 | KYTX |
Kyverna Therapeutics, Inc.
|
644,421 | $5,561,353 | |
| 7 | MIST |
Milestone Pharmaceuticals Inc.
|
4,118,321 | $4,900,801 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
131,364 | $4,166,866 |
All Filings in TRVI
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,669,957 | 223,802 | Shares | Defined | 2026-05-14 | |
| 2024-06-30 | $774,800 | 260,000 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $897,000 | 260,000 | Shares | Defined | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||